Inpyrfluxam Patent Landscape Analysis

Inpyrfluxam is a fungicide developed by Sumitomo Chemical, commercialised through the INDIFLIN® brand and products such as Excalia®.

The retained landscape covers 50 patent families across 14 consolidated owner groups. Two-active combination is the thickest protection layer (33 families), with manufacturing route and formulation claims providing additional constraint.

35 of the 50 retained families carry a grant or national pending reading. 2 families are held by China-based applicants. 8 live families have a nominal term ending within five years. Position as at November 2026.

This 42-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.